Sergey Yu. Martsevich

Sergey Yu. Martsevich

Auto-generated profile, based on publicly available information

Sergey Yu. Martsevich

National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2012 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
BCB R Chaitman
B R Chaitman
AHA P Ho
A P Ho
MBM O Behm
M O Behm
JRJ F Rowe
J F Rowe
JPJ S Palcza
J S Palcza
RBR L Blanchard
R L Blanchard

1 April 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
AKA. V. Kontsevaya
A. V. Kontsevaya
AKA. M. Kalinina
A. M. Kalinina
SASergey Avdeev
Sergey Avdeev
MAM. V. Agaltsov
M. V. Agaltsov
БДБ. Ю. Джонова
Б. Ю. Джонова
Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.

20 February 2013 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Closed access
SBSergey Boytsov
Sergey Boytsov
SMS. Yu. Martsevich
S. Yu. Martsevich
NKN. P. Kutishenko
N. P. Kutishenko
LDL. Yu. Drozdova
L. Yu. Drozdova
MLM. M. Lukyanov
M. M. Lukyanov
MGM. I. Ginzburg
M. I. Ginzburg
The article presents the main goals, tasks, principles, and methodological aspects of the cardiology register development. The authors describe the main types of registers, provide the examples, and specify the key principles of the register development and maintenance. In addition, they discuss the role of both long- and short-term registers in solving a wide range of important research tasks, particularly in the areas of effectiveness and safety of cardiovascular pharmacotherapy and the survival prognosis for specific nosological forms. The task-specific limitations of registers are also discussed.

3 September 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
YLYulia Lukina
Yulia Lukina
NKN. P. Kutishenko
N. P. Kutishenko
SMS. Yu. Martsevich
S. Yu. Martsevich
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. Development, testing and validation of the original questionnaire “Adherence Scale” (AS) in the PRIORITY and ANTEY observational studies (OS).Materials and methods. The OS PRIORITY assessed adherence to statins in 298 patients with high and very high cardiovascular risk for 3 months. The OS ANTEY assessed adherence to oral anticoagulants in 201 patients with non-valvular atrial fibrillation for 1 year. Adherence was assessed using the original AS questionnaire, for which external validation was performed (with the calculation of the Cohen's Kappa coefficient). The reference methods were the validated questionnaire and direct medical interview. And internal validation was performed (consistency of questions on the AS using Spearman's correlation analysis). The sensitivity, specificity (ROC analysis) and retest reliability of the adherence scale (Cronbach's alpha) were also determined.Results. In the OS PRIORITY Cohen's kappa for the AS and the reference method of direct medical survey was 0.76 (high consistency), and for the AS and the reference method of the validated questionnaire=0.28 (low consistency). High internal consistency of the questionnaire questions (correlation coefficient=0.78, p<0.0001) confirms the internal validity of the adherence scale. Evaluation of the main characteristics of the modified AS in the OS ANTEY showed high consistency between the results of the AS and the validated questionnaire: Cohen's kappa=0.94 (high external validity of the AS). The retest reliability of the AS was 0.76 (Cronbach's alpha). The internal consistency of the questionnaire was confirmed by a strong and statistically significant correlation between the test questions: Spearman's correlation coefficient=0.80, p<0.0001. The sensitivity of the test, determined using the ROC analysis, was 89%, and the specificity was 62%.Conclusion. The developed and tested new original questionnaire (modified version) – the AS – showed high indicators of reliability, validity and sensitivity. This ensures its reliability and ease of use for assessing various types of adherence and determining the leading factors of non-adherence, and also allows its use in scientific studies and clinical practice.

3 July 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YLYulia Lukina
Yulia Lukina
NKN. P. Kutishenko
N. P. Kutishenko
SMS. Yu. Martsevich
S. Yu. Martsevich
ODOxana M. Drapkina
Oxana M. Drapkina
СМС. Ю. Марцевич
С. Ю. Марцевич
The problem of medication adherence is still relevant, and the search for a reliable method for its diagnosis continues. One of the most convenient and promising ways to assess medication adherence, both in research and actual clinical practice, is the use of various questionnaires and scores. Currently, several dozen different questionnaires and scores are presented in Russia and other countries. All of them are indirect methods of adherence assessment and are characterized by subjectivity. The article presents data on the most famous and widely used foreign adherence scales (the 4- and 8-item Morisky Medication Adherence Scale (MMAS-4 and MMAS-8), Hill-Bone, SEAMS, BMQ, MARS, etc.) and several questionnaires proposed by Russian authors (the National Society of Evidence-based Pharmacotherapy Adherence Scale, the Quantitative Adherence Questionnaire and the National Questionnaire of Treatment Compliance). The main characteristics of the described scales, their advantages, disadvantages and prospects for use in studies and clinical practice are considered. There are following conclusions: 1) none of the current questionnaires is devoid of subjectivity; 2) almost all questionnaires overestimate medication adherence, do not fully diagnose nonadherence, and often determine only specific type of adherence; 3) even validated questionnaires, which used in patients with different diseases in various countries, can have different values of sensitivity, specificity and reliability — from excellent to very poor; 4) in this regard, the results should be skeptically and cautiously interpreted; 5) in actual clinical practice, preference should be given to concise scales that include no more than 10 questions, with a simple scoring system, preferably validated with using well-known criteria from large clinical trials; 6) to improve the diagnosis accuracy, usage of several available methods for assessing medication adherence is recommended.

20 December 2018 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
NKN. P. Kutishenko
N. P. Kutishenko
MLM. M. Lukyanov
M. M. Lukyanov
АЗА. В. Загребельный
А. В. Загребельный
NDN. A. Dmitrieva
N. A. Dmitrieva
СМС. Ю. Марцевич
С. Ю. Марцевич
Госпитальный регистр больных, перенесших острое нарушение мозгового кровообращения (РЕГИОН): портрет заболевшего и исходы стационарного этапа лечения